Research & Development

哥哥干干姐姐上海银行遭TCL举牌:第三大股东也同日出手 是何考虑?


  充滿欲望的伊秩斜這時候需要幫助,需要一個能隨時告訴他軍臣單于病情的人。   “如果發生了一些變故呢?”哥哥   雲瑯等了一會,見那三個家伙都沒有要死的征兆,就來到了棺槨邊上,小心的探出頭去。干   謝寧左手重重的在右手心里砸一下迅速的就出了賬房,曹襄剛剛要說話,謝寧又從外面鑽進來了,傻笑著對甦稚道︰“活的可以麼?”   曹襄端著一碗羊肉從遠處過來了,還沒說話,看到羊肉之後的謝寧就再一次匍匐在地上,瘋狂的嘔吐。干姐姐   如意抱著胸口小心的道︰“是一群紈褲……”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo